'Salvage cytoreductive surgery for pelvic side wall recurrent endometrial cancer: Robotic combined laterally extended endopelvic resection (LEER) and laterally extended pelvic resection (LEPR) debulking'

Mariano Catello Di Donna, Giuseppe Cucinella, Gabriele Cucinella, Giulia Zaccaria, Antonio Simone Laganà, Giovanni Scambia, Vito Chiantera

Research output: Contribution to journalArticle

Abstract

Endometrial cancer is the most common gynecological malignancy, and most patients present at an early-stage. However, approximately 15% of confined-uterus endometrial cancer patients will see their cancer return. Treatment options for recurrent endometrial cancer depend on the patient’s level of fitness, tumor dissemination and prior treatment. For localized resectable pelvic disease, salvage cytoreductive surgery may improve survival.1 Laterally extended endopelvic resection, en-bloc resection of the pelvic tumor and sidewall structures, represents an option for salvage treatment in cases of isolated recurrence involving the pelvic side wall.2
Original languageEnglish
Pages (from-to)126-127
Number of pages2
JournalInternational Journal of Gynecological Cancer
Volume33
DOIs
Publication statusPublished - 2022

Keywords

  • Cytoreduction surgical procedures
  • Endometrial Neoplasms
  • Gynecologic Surgical Procedures
  • Lymph Nodes
  • Neoplasm Recurrence, Local

Fingerprint

Dive into the research topics of ''Salvage cytoreductive surgery for pelvic side wall recurrent endometrial cancer: Robotic combined laterally extended endopelvic resection (LEER) and laterally extended pelvic resection (LEPR) debulking''. Together they form a unique fingerprint.

Cite this